BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
112 results:

  • 1. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours.
    Zago Baltazar R; Claerhout S; Vander Borght S; Spans L; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Renard M; van den Hout MF; Vernemmen A; Libbrecht L; De Roo AK; Mazzeo F; van Marcke C; Deraedt K; Bourgain C; Vanden Bempt I
    J Pathol Clin Res; 2024 May; 10(3):e12376. PubMed ID: 38738521
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 4. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
    Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
    J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Metastatic Undifferentiated Melanoma Mimicking a Primary bone Tumor: A Potential Diagnostic Pitfall.
    Wills A; Dibbern M; Frierson HF; Raghavan SS
    Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Histological Classification and diagnosis of Sellar/Parasellar Tumors].
    Nishioka H
    No Shinkei Geka; 2023 Sep; 51(5):789-798. PubMed ID: 37743330
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung cancer Patients.
    Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and prognostic features of Langerhans cell histiocytosis in adults.
    Sato A; Kobayashi M; Yusa N; Ogawa M; Shimizu E; Kawamata T; Yokoyama K; Ota Y; Ichinohe T; Ohno H; Mori Y; Sakaida E; Kondo T; Imoto S; Nannya Y; Mitani K; Tojo A
    Cancer Sci; 2023 Sep; 114(9):3687-3697. PubMed ID: 37364599
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for braf mutation.
    Lu L; Zhou J; Yan X; Jin R; Deng S; Lu W; Chen D
    Medicine (Baltimore); 2023 May; 102(20):e33846. PubMed ID: 37335698
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hairy Cell Leukemia: Where Are We in 2023?
    Mendez-Hernandez A; Moturi K; Hanson V; Andritsos LA
    Curr Oncol Rep; 2023 Aug; 25(8):833-840. PubMed ID: 37097545
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Utility of Retrospective Molecular Analysis in Diagnostically Challenging Mesenchymal Neoplasms.
    Mindiola Romero AE; Tafe LJ; Green DC; Deharvengt SJ; Winnick KN; Tsongalis GJ; Baker ML; Linos K; Levy JJ; Kerr DA
    Int J Surg Pathol; 2023 Dec; 31(8):1473-1484. PubMed ID: 36911994
    [No Abstract]    [Full Text] [Related]  

  • 13. Assessment of Frailty Index at 66 Years of Age and Association With Age-Related Diseases, Disability, and Death Over 10 Years in Korea.
    Jang J; Jung H; Shin J; Kim DH
    JAMA Netw Open; 2023 Mar; 6(3):e2248995. PubMed ID: 36862415
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Advanced Appendiceal cancer with Systematic Metastasis without Gastrointestinal Symptoms Found by Subcutaneous Tumor.
    Nakamura S; Ochiai Y; Nishihara Y; Koyanagi A; Miura Y; Kikuchi D; Takazawa Y; Kuroyanagi H; Hoteya S
    Intern Med; 2023 Sep; 62(18):2655-2660. PubMed ID: 36754410
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Erdheim-Chester Disease with braf V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
    Prabhakaran N; Jour G; Balar A; Ward N
    Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
    Kemps PG; Zondag TCE; Arnardóttir HB; Solleveld-Westerink N; Borst J; Steenwijk EC; van Egmond D; Swennenhuis JF; Stelloo E; Trambusti I; Verdijk RM; van Noesel CJM; Cleven AHG; Scheijde-Vermeulen MA; Koudijs MJ; Krsková L; Hawkins C; Egeler RM; Brok J; von Bahr Greenwood T; Svojgr K; Beishuizen A; van Laar JAM; Pötschger U; Hutter C; Sieni E; Minkov M; Abla O; van Wezel T; van den Bos C; van Halteren AGS
    Blood Adv; 2023 Feb; 7(4):664-679. PubMed ID: 36083130
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Response to treatment with an ALK-TKI in a patient with advanced lung adenocarcinoma with concurrent ALK fusion and high PD-L1 expression: A case report.
    Zhang Y; Fang H; Hong J; Wang X; Wang H; Pan G
    Medicine (Baltimore); 2022 Aug; 101(33):e30094. PubMed ID: 35984185
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. braf and NRAS prognostic values in conjunctival melanoma: analysis and literature review.
    Valentín-Bravo FJ; Pérez-Rodríguez Á; García-Álvarez C; García-Lagarto E; Saornil-Álvarez MA
    Arq Bras Oftalmol; 2023; 86(5):e20230071. PubMed ID: 35544941
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.